These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9579798

  • 1. A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm.
    Ragupathi G, Koganty RR, Qiu D, Lloyd KO, Livingston PO.
    Glycoconj J; 1998 Mar; 15(3):217-21. PubMed ID: 9579798
    [Abstract] [Full Text] [Related]

  • 2. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
    Ragupathi G, Howard L, Cappello S, Koganty RR, Qiu D, Longenecker BM, Reddish MA, Lloyd KO, Livingston PO.
    Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
    [Abstract] [Full Text] [Related]

  • 3. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
    Ragupathi G, Deshpande PP, Coltart DM, Kim HM, Williams LJ, Danishefsky SJ, Livingston PO.
    Int J Cancer; 2002 May 10; 99(2):207-12. PubMed ID: 11979435
    [Abstract] [Full Text] [Related]

  • 4. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.
    Longenecker BM, Reddish M, Koganty R, MacLean GD.
    Adv Exp Med Biol; 1994 May 10; 353():105-24. PubMed ID: 7527178
    [Abstract] [Full Text] [Related]

  • 5. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant.
    Longenecker BM, Reddish M, Koganty R, MacLean GD.
    Ann N Y Acad Sci; 1993 Aug 12; 690():276-91. PubMed ID: 7690215
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.
    Keding SJ, Danishefsky SJ.
    Proc Natl Acad Sci U S A; 2004 Aug 17; 101(33):11937-42. PubMed ID: 15280546
    [Abstract] [Full Text] [Related]

  • 15. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
    Ragupathi G, Koide F, Sathyan N, Kagan E, Spassova M, Bornmann W, Gregor P, Reis CA, Clausen H, Danishefsky SJ, Livingston PO.
    Cancer Immunol Immunother; 2003 Oct 17; 52(10):608-16. PubMed ID: 12811527
    [Abstract] [Full Text] [Related]

  • 16. Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines.
    Wu J, Guo Z.
    Bioconjug Chem; 2006 Oct 17; 17(6):1537-44. PubMed ID: 17105234
    [Abstract] [Full Text] [Related]

  • 17. From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.
    Zhu J, Wan Q, Lee D, Yang G, Spassova MK, Ouerfelli O, Ragupathi G, Damani P, Livingston PO, Danishefsky SJ.
    J Am Chem Soc; 2009 Jul 08; 131(26):9298-303. PubMed ID: 19518111
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines.
    Pan Y, Chefalo P, Nagy N, Harding C, Guo Z.
    J Med Chem; 2005 Feb 10; 48(3):875-83. PubMed ID: 15689172
    [Abstract] [Full Text] [Related]

  • 19. Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidates.
    Huo CX, Zheng XJ, Xiao A, Liu CC, Sun S, Lv Z, Ye XS.
    Org Biomol Chem; 2015 Mar 28; 13(12):3677-90. PubMed ID: 25679360
    [Abstract] [Full Text] [Related]

  • 20. Allylmalonamide as a bivalent linker: synthesis of biantennary GM3-saccharide--keyhole limpet hemocyanin glycoconjugate and the immune response in mice.
    Zou W, Abraham M, Gilbert M, Wakarchuk WW, Jennings HJ.
    Glycoconj J; 1999 Sep 28; 16(9):507-15. PubMed ID: 10815987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.